Xeris Biopharma (XERS) 2025 Outlook: Earnings & Pipeline
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Learn about effective wealth building actions for this year that can enhance your savings and investment strategies for long-term success.
24,006 articlesA thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
As Omada Health eyes the 2025 earnings journey, investors want a clear read on growth, margins, and risks. This guide...
QuantumScape has fallen hard in early 2026. This guide walks you through what would move the stock higher, what could...
SentinelOne hit a $1 billion ARR milestone as revenue growth decelerated and operating margins improved, but investor...
Travel demand lifted airline stocks as Delta Air Lines and American Airlines posted upbeat guidance and revenue data ...
Lumentum’s March 23 S&P 500 inclusion has sparked renewed buying and a broader market debate about how far the rally ...
Uber reports record cash flow and a bold autonomous-vehicle push as investors wonder if the uber stock price predicti...
In Q1 2026, new homes held prices steady while resale values declined, signaling a pricing strategy where discounts r...
A famed market forecaster is signaling a bold by-year-end target for the S&P 500, driven by resilient earnings and a ...
Ford kicked off the year with strong truck demand and a raised outlook. Now the automaker aims to sustain momentum in...
Explore how Pixelworks PXLW 2026 earnings shape a small-cap tech stock. This guide breaks down the key metrics, poten...
Eli Lilly kicked off 2026 with blockbuster sales and higher guidance, reigniting talk of a path to $1800 for Lilly st...